Search in:

Artificial Cells, Nanomedicine, and Biotechnology

An International Journal

Volume 47, 2019 - Issue 1

Submit an article Journal homepage

Open access

2,029

Views

CrossRef citations to date

Altmetric

Research Article

Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

Jaleh Khanifara Department of Biology, Payame Noor University, Tehran, Iran

Ali Hatef Salmanianb Department of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, IranCorrespondence[email protected]

Reza Haji Hosseinia Department of Biology, Payame Noor University, Tehran, Iran

Jafar Amanic Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranCorrespondence[email protected]

Rohoallah Kazemid Department of Molecular Biology, Green Gene Company, Tehran, Iran

Pages 2593-2604 | Received 05 Jan 2019, Accepted 09 May 2019, Published online: 26 Jun 2019

Cite this article
https://doi.org/10.1080/21691401.2019.1629947
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Li Zhang, Changwei Yang, Yingxiang Song, Tao Sheng, Junyan Li, Jicheng Yu, Xiaohong Wu & Xiao Ye. (2023) Advances of nanoparticles in transmucosal drug delivery. Nano Research.
Crossref

Shadi Mosadegh, Hamid Abtahi, Jafar Amani, Shohreh Zare Karizi & Ali Hatef Salmanian. (2023) Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD. Microbial Pathogenesis 184, pages 106344.
Crossref

Elaheh Gheybi, Ahmad Asoodeh & Jafar Amani. (2023) Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice. BMC Cancer 23:1.
Crossref

Qi Wei, Shixian Liu, Xu Huang, Hua Xin & Jianxun Ding. (2023) Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms. Biosafety and Health 5:1, pages 45-61.
Crossref

Pravil Pokharel, Sabin Dhakal & Charles M. Dozois. (2023) The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen. Microorganisms 11:2, pages 344.
Crossref

Yan-Wei Wu, Wan-Yu Wang & Yu-Hung Chen. (2022) Positively charged nanocomplex modulates dendritic cell differentiation to enhance Th1 immune response. Materials Today Bio 17, pages 100480.
Crossref

Sareh Bagheri-Josheghani, Bita Bakhshi & Shahin Najar-peerayeh. (2022) The Influence of Nanoparticle on Vaccine Responses against Bacterial Infection. Journal of Nanotechnology 2022, pages 1-15.
Crossref

Mohit Kumar, Raghav Dogra & Uttam Kumar Mandal. (2022) Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 74, pages 103533.
Crossref

Matilde Durán-Lobato, Ana María López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente-Campo, Dolores Torres & María José Alonso. (2021) Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Advanced Drug Delivery Reviews 176, pages 113899.
Crossref

Tony Jin, Tracy Liu, Edmond Lam & Audrey Moores. (2021) Chitin and chitosan on the nanoscale. Nanoscale Horizons 6:7, pages 505-542.
Crossref

Gina M. Mohammed, Heba ElSayed ElZorkany, Khaled Y. Farroh, Wafaa R. Abd El-Aziz & Hisham A. Elshoky. (2021) Potential improvement of the immune response of chickens against E. coli vaccine by using two forms of chitosan nanoparticles. International Journal of Biological Macromolecules 167, pages 395-404.
Crossref

Melibea Berzosa, Yadira Pastor, Juan M. Irache & Carlos Gamazo. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 3 27 .

Soojin Shim & Han Sang Yoo. (2020) The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery. Marine Drugs 18:12, pages 605.
Crossref

Youming Xiong, Meng Xiong, Yangyang Li, Jin Qian, Yuwei Li, Xu Han, Jing Tan, Yanli Luo, Qiuxiang Wang & Caiqin Qin. (2020) Chitosan oligosaccharide combined with running benefited the immune status of rats. International Immunopharmacology 88, pages 106915.
Crossref

Sabrina Mühlen & Petra Dersch. (2020) Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli. Frontiers in Cellular and Infection Microbiology 10.
Crossref

Farhad Gilavand, Abdolrazagh Marzban, Gholamhossein Ebrahimipour, Neda Soleimani & Mehdi Goudarzi. (2020) Designation of chitosan nano-vaccine based on MxiH antigen of Shigella flexneri with increased immunization capacity. Carbohydrate Polymers 232, pages 115813.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date